| Product Code: ETC13185979 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Stents Market was valued at USD 12.5 Billion in 2024 and is expected to reach USD 19 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The global stents market is experiencing steady growth driven by the increasing prevalence of cardiovascular diseases and a growing aging population. Stents are small, expandable tubes used to treat narrowed or weakened arteries in the body. The market is characterized by technological advancements, such as the development of drug-eluting stents that help prevent re-narrowing of arteries post-procedure. Key players in the market are investing in research and development to introduce innovative stent designs and materials, improving patient outcomes and reducing the need for repeat procedures. Geographically, North America and Europe dominate the market due to high healthcare expenditure and advanced healthcare infrastructure. However, the Asia Pacific region is expected to witness significant growth due to rising awareness, improving healthcare facilities, and a growing patient population.
The Global Stents Market is experiencing significant growth due to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive procedures. Technological advancements such as drug-eluting stents and bioresorbable stents are driving market expansion. Additionally, the aging population and growing adoption of unhealthy lifestyles contribute to the market`s growth. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities for market players to expand their presence. However, stringent regulatory requirements and the high cost of stent procedures remain key challenges. The market is expected to continue growing, driven by ongoing research and development efforts to improve stent designs and materials, as well as the increasing focus on personalized medicine and precision healthcare.
The Global Stents Market faces several challenges including intense competition among key players leading to pricing pressures, stringent regulatory requirements for product approval, and the potential for product recalls due to safety concerns. Additionally, the market is witnessing a shift towards alternative treatment options such as drug therapy or minimally invasive procedures, impacting the demand for stents. Furthermore, the high cost of stent procedures and limited reimbursement policies in certain regions pose challenges for market growth. Innovations in stent technology and materials, along with the need for personalized treatment solutions, are also driving the market dynamics. Overall, the Global Stents Market must navigate these challenges to sustain growth and meet the evolving healthcare needs of patients worldwide.
The Global Stents Market is primarily driven by the increasing prevalence of cardiovascular diseases and the growing aging population globally. Technological advancements in stent designs and materials have also contributed to the market growth, leading to improved efficacy and reduced complications in stent procedures. Additionally, the rising adoption of minimally invasive procedures and the increasing awareness about the benefits of stents in treating coronary artery diseases are fueling market expansion. Furthermore, the surge in demand for drug-eluting stents, which release medication to prevent restenosis, is propelling market growth. Government initiatives to improve healthcare infrastructure and access to advanced medical treatments are further boosting the demand for stents worldwide.
Government policies related to the Global Stents Market primarily focus on regulating the quality, safety, and efficacy of stents to ensure patient safety and promote innovation. Regulatory bodies such as the FDA in the United States and the European Medicines Agency (EMA) in Europe set standards for stent approval, requiring manufacturers to conduct rigorous clinical trials and adhere to strict manufacturing practices. Additionally, healthcare reimbursement policies play a significant role in market dynamics, influencing the pricing and adoption of stents. Governments also aim to promote cost-effectiveness by encouraging the use of generic and lower-cost stents. Overall, government policies in the Global Stents Market aim to strike a balance between fostering innovation, ensuring patient safety, and controlling healthcare costs.
The Global Stents Market is expected to witness steady growth in the coming years, driven by the increasing prevalence of cardiovascular diseases and the rising adoption of minimally invasive procedures. Technological advancements in stent designs and materials, such as bioresorbable stents, are also anticipated to drive market growth. Additionally, the growing geriatric population and lifestyle changes leading to risk factors for heart diseases are likely to contribute to the market expansion. Emerging economies in Asia-Pacific and Latin America present significant opportunities for market players due to improving healthcare infrastructure and increasing healthcare expenditure. However, stringent regulatory requirements and the high cost of stent procedures may pose challenges to market growth. Overall, the Global Stents Market is projected to experience sustained growth in the foreseeable future.
The global stents market is experiencing varying growth trends across different regions. In Asia, the market is witnessing rapid expansion due to the increasing prevalence of cardiovascular diseases and the growing adoption of minimally invasive procedures. North America remains a key market for stents, driven by advanced healthcare infrastructure, high healthcare expenditure, and a large patient pool. In Europe, the market is characterized by stringent regulatory frameworks and the presence of key market players. The Middle East and Africa region is witnessing steady growth in the stents market, supported by improving healthcare infrastructure and rising awareness about cardiovascular diseases. Latin America is also showing promising growth opportunities, attributed to the increasing healthcare investments and the rising burden of cardiovascular disorders in the region.
Global Stents Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Stents Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Global Stents Market - Industry Life Cycle |
3.4 Global Stents Market - Porter's Five Forces |
3.5 Global Stents Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Stents Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F |
3.8 Global Stents Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Stents Market Trends |
6 Global Stents Market, 2021 - 2031 |
6.1 Global Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Stents Market, Revenues & Volume, By Coronary Stents, 2021 - 2031 |
6.1.3 Global Stents Market, Revenues & Volume, By Peripheral Stents, 2021 - 2031 |
6.1.4 Global Stents Market, Revenues & Volume, By Stent-Related Implants, 2021 - 2031 |
6.2 Global Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Stents Market, Revenues & Volume, By Metallic Biomaterials, 2021 - 2031 |
6.2.3 Global Stents Market, Revenues & Volume, By Polymeric Biomaterials, 2021 - 2031 |
6.2.4 Global Stents Market, Revenues & Volume, By Natural Biomaterials, 2021 - 2031 |
6.3 Global Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Stents Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.3.3 Global Stents Market, Revenues & Volume, By Cardiac Centers, 2021 - 2031 |
6.3.4 Global Stents Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Stents Market, Overview & Analysis |
7.1 North America Stents Market Revenues & Volume, 2021 - 2031 |
7.2 North America Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Stents Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.5 North America Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Stents Market, Overview & Analysis |
8.1 Latin America (LATAM) Stents Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Stents Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
8.5 Latin America (LATAM) Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Stents Market, Overview & Analysis |
9.1 Asia Stents Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Stents Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
9.5 Asia Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Stents Market, Overview & Analysis |
10.1 Africa Stents Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Stents Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
10.5 Africa Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Stents Market, Overview & Analysis |
11.1 Europe Stents Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Stents Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
11.5 Europe Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Stents Market, Overview & Analysis |
12.1 Middle East Stents Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Stents Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Stents Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
12.5 Middle East Stents Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Stents Market Key Performance Indicators |
14 Global Stents Market - Export/Import By Countries Assessment |
15 Global Stents Market - Opportunity Assessment |
15.1 Global Stents Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Stents Market Opportunity Assessment, By Biomaterial, 2021 & 2031F |
15.4 Global Stents Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Stents Market - Competitive Landscape |
16.1 Global Stents Market Revenue Share, By Companies, 2024 |
16.2 Global Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |